Most cited papers from Brain Tumour Research

Brain Tumour Research

What are the most cited papers from Brain Tumour Research?

The most cited paper from Brain Tumour Research is "Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines" (Clotilde Théry et al., 2018), with 11,535 citations. Next come "Identification of human brain tumour initiating cells" (7,487) and "International network of cancer genome projects" (2,439).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 223 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines Clotilde Théry et al. · Journal of Extracellular Vesicles Open access382 authors	23 Nov 2018	11,535
2	Identification of human brain tumour initiating cells Sheila Kumari Singh, Cynthia E Hawkins, Ian D. Clarke et al. · Nature	Nov 2004	7,487
3	International network of cancer genome projects Jennifer L. Jennings et al. · Nature Open access256 authors	13 Apr 2010	2,439
4	The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions Rose Oughtred, Jennifer Rust, Christie Chang et al. · Protein Science Open access	18 Oct 2020	2,026
5	Intertumoral Heterogeneity within Medulloblastoma Subgroups Florence M.G. Cavalli et al. · Cancer Cell Open access	Jun 2017	1,290
6	Nanomedicine Betty Y.S. Kim, James T. Rutka, Warren C. W. Chan · New England Journal of Medicine	15 Dec 2010	1,147
7	European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas Michael Weller et al. · The Lancet Oncology Open access	5 May 2017	1,122
8	Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer Alan Storey, Miranda Thomas, Ann Kalita et al. · Nature	May 1998	985
9	DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis Felix Sahm et al. · The Lancet Oncology Open access	14 Mar 2017	876
10	Comprehensive Analysis of Hypermutation in Human Cancer Brittany B. Campbell et al. · Cell Open access	19 Oct 2017	817
11	Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma Paul A. Northcott et al. · Nature Open access	20 Jun 2014	684
12	Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult Disease Barbara S. Paugh, Chunxu Qu, Chris J. Jones et al. · Journal of Clinical Oncology Open access	17 May 2010	670
13	Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations Pawel Buczkowicz et al. · Nature Genetics Open access	6 Apr 2014	665
14	EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours Émilie Le Rhun, Michael Weller, Dieta Brandsma et al. · Annals of Oncology Open access	5 May 2017	649
15	Epigenomic alterations define lethal CIMP-positive ependymomas of infancy Stephen C. Mack et al. · Nature Open access	Feb 2014	626
16	Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge Dominik Sturm, Sebastian Bender, David Jones et al. · Nature reviews. Cancer ReviewOpen access	24 Jan 2014	567
17	Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases Philip Haycock et al. · JAMA Oncology Open access198 authors	27 Feb 2017	538
18	Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer Young Seok Ju et al. · eLife Open access	30 Sep 2014	509
19	Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas Scott T. Ryall et al. · Cancer Cell Open access	Apr 2020	491
20	Childhood cerebellar tumours mirror conserved fetal transcriptional programs Maria Claudia Vladoiu et al. · Nature Open access	May 2019	469
21	Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors Sharareh Gholamin et al. · Science Translational Medicine	15 Mar 2017	435
22	Comparison of RNA-seq and microarray-based models for clinical endpoint prediction Wenqian Zhang et al. · Genome biology Open access	24 Jun 2015	432
23	Clonal selection drives genetic divergence of metastatic medulloblastoma Xiaochong Wu et al. · Nature Open access	Feb 2012	416
24	A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering Ellen Birgitte Lane, Elizabeth L. Rugg, Harshad A Navsaria et al. · Nature	Mar 1992	412
25	Presentation of childhood CNS tumours: a systematic review and meta-analysis Sophie Wilne, Jacqueline Collier, Colin Kennedy et al. · The Lancet Oncology Review	21 Jul 2007	409
26	Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas Ana Guerreiro Stücklin et al. · Nature Communications Open access	25 Sep 2019	389
27	Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers Adam Shlien et al. · Nature Genetics Open access	2 Feb 2015	389
28	YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation Africa Fernández-L, Paul A. Northcott, James Dalton et al. · Genes & Development Open access	Dec 2009	382
29	Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis Eric M. Thompson et al. · The Lancet Oncology Open access107 authors	11 Mar 2016	377
30	Cross-species genomics matches driver mutations and cell compartments to model ependymoma Robert Arnold Johnson et al. · Nature Open access	Jul 2010	371
31	Functional Enhancers Shape Extrachromosomal Oncogene Amplifications Andrew R. Morton, Nergiz Dogan-Artun, Zachary J. Faber et al. · Cell Open access	Nov 2019	370
32	Pediatric low-grade glioma in the era of molecular diagnostics Scott T. Ryall, Uri Tabori, Cynthia E Hawkins · Acta Neuropathologica Communications Open access	12 Mar 2020	356
33	The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants Kristian W. Pajtler et al. · Acta Neuropathologica Open access	17 Nov 2016	341
34	Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity Laura M. Richards et al. · Nature Cancer	4 Jan 2021	340
35	MRI Surrogates for Molecular Subgroups of Medulloblastoma Sébastien Perreault, Vijay Ramaswamy, Achal Singh Achrol et al. · American Journal of Neuroradiology Open access	15 May 2014	333
36	Keratins (Kl6 and Kl7) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro Irene M. Leigh, Harshad A Navsaria, Patricia E. Purkis et al. · British Journal of Dermatology	Oct 1995	331
37	The hematopoietic-specific adaptor protein Gads functions in T-cell signaling via interactions with the SLP-76 and LAT adaptors Stanley K. Liu, Nan Fang, Gary A. Koretzky et al. · Current Biology Open access	1999	330
38	The Role of Hypoxia in Glioblastoma Invasion Ana Rita Monteiro, Richard J. Hill, Geoffrey John Pilkington et al. · Cells Open access	22 Nov 2017	322
39	Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency Carolyn D. Hurst, Olivia Alder, Fiona M. Platt et al. · Cancer Cell Open access	Nov 2017	317
40	Quiescent Sox2+ Cells Drive Hierarchical Growth and Relapse in Sonic Hedgehog Subgroup Medulloblastoma Robert J. Vanner et al. · Cancer Cell Open access	19 Jun 2014	315
41	Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts David W. Ellison, Mehmet Koçak, Dominique Figarella‐Branger et al. · Journal of Negative Results in BioMedicine Open access	31 May 2011	315
42	A monoclonal antibody against neurofilament protein specifically labels a subpopulation of rat sensory neurones Sally N. Lawson, A. A. Harper, Edna I. Harper et al. · The Journal of Comparative Neurology	10 Sep 1984	313
43	Stalled developmental programs at the root of pediatric brain tumors Selin Jessa et al. · Nature Genetics Open access	25 Nov 2019	309
44	Medulloblastoma in the age of molecular subgroups: a review Kyle Juraschka, Michael D. Taylor · Journal of Neurosurgery Pediatrics Open access	Oct 2019	297
45	Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas Kristian W. Pajtler et al. · Acta Neuropathologica Open access	16 Jun 2018	273
46	Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer Ricardo Romao Nazario Leao, Joana Dias Apolónio, Dong‐Hyun Lee et al. · Journal of Biomedical Science Open access	11 Mar 2018	266
47	Assessment of Requirements for IL-15 and IFN Regulatory Factors in Uterine NK Cell Differentiation and Function During Pregnancy Ali A. Ashkar, Gordon P. Black, Qingxia Wei et al. · The Journal of Immunology Open access	Sep 2003	265
48	Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study Richard Guy Grundy, Sophie Wilne, Claire L. Weston et al. · The Lancet Oncology	24 Jul 2007	264
49	Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors Jonathon Torchia et al. · Cancer Cell Open access118 authors	Dec 2016	261
50	Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma Laura Donovan et al. · Nature Medicine Open access	27 Apr 2020	256

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.